Lung cancer trials in France

In France 316 Also abroad 2746

316 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Where
Avignon, Bordeaux Cedex, Limoges, Quimper Cedex, Rouen Cedex, Suresnes, Toulon Cedex 9
Age
18 years to 95 years
People
630 worldwide
Run by
AstraZeneca
See details and how to joinNCT05061550 · EU 2023-508852-21-00
No phaseTaking people
Short-term Effects of Osteopathic Manipulations on Heart Rate Variability in Lung Cancer Patients - A Randomized Pilot Study
Where
Avignon
Age
18 years and over
People
80
Run by
Centre Hospitalier Henri Duffaut - Avignon
See details and how to joinNCT06822348
Phase 3Taking people
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Where
Angers, Créteil, La Tronche, Lyon, Marseille, Paris, Pessac, Rennes, Saint-Herblain, Saint-Mandé, Strasbourg
Age
18 years and over
People
695 worldwide
Run by
Gilead Sciences
See details and how to joinNCT06801834
Phase 3Taking people
A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer
Where
Angers, Avignon Cedex 9, Bordeaux, Bron, Créteil, Grenoble Cedex 9, Le Mans Cedex 9, Lille, Limoges Cedex 1, Lyon, Lyon Cedex 04, Marseille, Montpellier Cedex 5, Paris, Pierre-Bénite, Quimper Cedex, Saint-Herblain, Suresnes, Toulon, Toulouse, Toulouse Cedex 9, Valenciennes, Villejuif
Age
18 years and over
People
263 worldwide
Run by
Zai Lab (US) LLC
See details and how to join2025-522818-23-00
Phase 1/2Taking people
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Where
Angers, Bordeaux, Boulogne-Billancourt, Bron, Caen Cedex 5, Dijon, Lille, Paris, Saint-Herblain, Suresnes, Toulouse Cedex 9, Villejuif
Age
18 years and over
People
616 worldwide
Run by
Revolution Medicines, Inc.
See details and how to joinNCT06162221 · EU 2025-521147-21-00
No phaseTaking people
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
Where
Angers, Avignon, Bayonne, Bordeaux, Caen, Chambéry, Cholet, Créteil, Dijon, La Roche-sur-Yon, Lille, Lorient, Marseille, Montpellier, Paris, Perpignan, Pierre-Bénite, Rouen, Saint-Nazaire, Saint-Priest-en-Jarez, Strasbourg, Tarbes, Vandœuvre-lès-Nancy, Vannes, Villejuif
Age
18 years and over
People
600 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04790253
Phase 3Taking people
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Where
Avignon, Bron, Créteil, Le Mans, Limoges, Lyon, Montpellier, Pierre-Bénite, Quimper, Saint-Herblain, Suresnes, Toulon, Valenciennes
Age
18 years and over
People
480 worldwide
Run by
Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT07218146
Phase 2Taking people
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
Where
Avignon, Rennes, Suresnes
Age
18 years and over
People
278 worldwide
Run by
AstraZeneca
See details and how to joinNCT07098338 · EU 2025-524843-11-00
Phase 3Taking people
Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body Radiotherapy
Where
Brest, Lyon
Age
18 years and over
People
418
Run by
University Hospital, Brest
See details and how to joinNCT07289646
Phase 1Taking people
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Where
Lyon, Paris, Toulouse Cedex 9
Age
18 years and over
People
300 worldwide
Run by
Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00
Phase 3Suspended
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Where
Angers, Bordeaux, Caen, Paris, Rennes Cedex 9, Saint-Herblain Cedex, Toulon
Age
18 years and over
People
621 worldwide
Run by
BioNTech SE
See details and how to joinNCT06712355 · EU 2024-515765-34-00
Phase 2Taking people
An Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Exon 20 Insertion and Uncommon/Single or Compound Epidermal Growth Factor Receptor Mutations
Where
Boulogne-Billancourt, Caen Cedex 9, Limoges, Lyon, Marseille, Paris, Pessac, Saint-Herblain, Strasbourg Cedex
Age
18 years and over
People
117 worldwide
Run by
Taiho Oncology Inc.
See details and how to join2023-503865-48-00
Phase 2/3Not yet taking people in France
IZABRIGHT-Lung01: Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI Therapy
Where
Angers, Bron, Grenoble Cedex 09, Marseille, Paris, Paris Cedex 20, Saint-Herblain, Strasbourg Cedex, Toulouse, Villejuif
Age
18 years and over
People
173 worldwide
Run by
Bristol-Myers Squibb Services Unlimited Company
See details and how to join2025-521908-22-00
Phase 1/2Taking people
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Where
Dijon, Paris, Rennes, Villejuif
Age
18 years and over
People
554 worldwide
Run by
Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00
Phase 3Suspended
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Where
Angers, Bordeaux Cedex, Boulogne-Billancourt, Bron, Caen Cedex 9, Créteil, Le Mans Cedex 9, Lyon, Lyon Cedex 04, Mulhouse, Nantes Cedex 2, Nimes Cedex 9, Paris, Paris Cedex 18, Pierre-Bénite, Rennes, Rouen Cedex, Saint-Herblain, Villefranche Sur Saone Cedex, Villejuif
Age
18 years and over
People
360 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07128199 · EU 2025-521775-31-00
No phaseTaking people
Study of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment
Where
Annecy, Chambéry, Grenoble
Age
18 years and over
People
63
Run by
University Hospital, Grenoble
See details and how to joinNCT07434947
Phase 2Not yet taking people in France
A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)
Where
Paris, Rennes, Toulouse, Villejuif
Age
18 years and over
People
80 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07871214
Phase 1Taking people
Study of Elironrasib (RMC-6291) and Daraxonrasib (RMC-6236) With Other Anti-Cancer Agents in Patients With RAS G12C-Mutated NSCLC - Subprotocol A
Where
Bordeaux, Bron, Caen Cedex 5, Dijon, Lille, Paris, Saint-Herblain, Suresnes, Toulouse Cedex 9, Villejuif
Age
18 years and over
People
330 worldwide
Run by
Revolution Medicines Inc.
See details and how to join2023-509571-16-00
No phaseTaking people
European Real-World Registry for Use of the Ion Endoluminal System
Where
Brest, Le Plessis-Robinson, Rouen
Age
18 years and over
People
1,200 worldwide
Run by
Intuitive Surgical
See details and how to joinNCT06923774
Phase 1Taking people
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Where
Vandœuvre-lès-Nancy
Age
18 years and over
People
180 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07261631
Phase 2Not yet taking people in France
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Where
Lyon, Marseille, Villejuif
Age
18 years and over
People
40 worldwide
Run by
Pfizer
See details and how to joinNCT07476287 · EU 2025-524686-24-00
Phase 3Taking people
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Where
Angers, Besancon Cedex, Boulogne-Billancourt, Limoges Cedex 1, Nancy Cedex, Paris, Villejuif
Age
18 years and over
People
1,410 worldwide
Run by
Pfizer
See details and how to joinNCT07222566 · EU 2025-523461-17-01
Phase 2/3Not yet taking people in France
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Where
Boulogne-Billancourt, Villejuif
Age
18 years and over
People
550 worldwide
Run by
Pfizer
See details and how to joinNCT07226999 · EU 2025-523522-41-00
Phase 1/2Taking people
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Where
Bordeaux, Dijon, Marseille, Paris
Age
18 years and over
People
162 worldwide
Run by
Pfizer
See details and how to joinNCT07227298 · EU 2025-523526-40-00
Phase 2Not yet taking people in France
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Where
Bron, Lyon Cedex 04, Paris, Pierre-Bénite, Villejuif
Age
18 years and over
People
120 worldwide
Run by
Pfizer
See details and how to joinNCT07489066 · EU 2025-524825-42-00